These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 2641028)

  • 1. A dose run-up and safety evaluation of nalmefene HCl in human volunteers.
    Fudala PJ; Johnson RE; Heishman SJ; Cone EJ; Henningfield JE
    NIDA Res Monogr; 1989; 95():451-2. PubMed ID: 2641028
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for the delivery of narcotic antagonists to the colon as their glucuronide conjugates.
    Simpkins JW; Smulkowski M; Dixon R; Tuttle R
    J Pharmacol Exp Ther; 1988 Jan; 244(1):195-205. PubMed ID: 3335997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nalmefene--a long-acting injectable opioid antagonist.
    Med Lett Drugs Ther; 1995 Oct; 37(960):97-8. PubMed ID: 7565300
    [No Abstract]   [Full Text] [Related]  

  • 4. The opioid receptor antagonist nalmefene reduces responding maintained by ethanol presentation: preclinical studies in ethanol-preferring and outbred Wistar rats.
    June HL; Grey C; Warren-Reese C; Durr LF; Ricks-Cord A; Johnson A; McCane S; Williams LS; Mason D; Cummings R; Lawrence A
    Alcohol Clin Exp Res; 1998 Dec; 22(9):2174-85. PubMed ID: 9884166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a narcotic antagonist (nalmefene) to suppress self-mutilative behavior in a stallion.
    Dodman NH; Shuster L; Court MH; Patel J
    J Am Vet Med Assoc; 1988 Jun; 192(11):1585-6. PubMed ID: 3410777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of nalmefene after a single or multiple intravenous doses in Chinese healthy volunteers].
    Liao RF; Zeng ZP; Wen YG
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1816-9. PubMed ID: 18971181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary trial of nalmefene for the treatment of emotional numbing in combat veterans with post-traumatic stress disorder.
    Glover H
    Isr J Psychiatry Relat Sci; 1993; 30(4):255-63. PubMed ID: 8163362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.
    Dunbar JL; Turncliff RZ; Dong Q; Silverman BL; Ehrich EW; Lasseter KC
    Alcohol Clin Exp Res; 2006 Mar; 30(3):480-90. PubMed ID: 16499489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies to maximize the efficacy of naltrexone for alcohol dependence.
    O'Malley SS
    NIDA Res Monogr; 1995; 150():53-64. PubMed ID: 8742772
    [No Abstract]   [Full Text] [Related]  

  • 10. Behavioral effects of 6-methylene naltrexone (nalmefene) in rhesus monkeys.
    France CP; Gerak LR
    J Pharmacol Exp Ther; 1994 Sep; 270(3):992-9. PubMed ID: 7932212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rapid, quantitative in vivo assay for narcotic antagonists.
    Katovich MJ; Simpkins JW; Song IC; Bodor N; Tuttle R
    Subst Alcohol Actions Misuse; 1984; 5(2):87-95. PubMed ID: 6540897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum naltrexone and 6-beta-naltrexol levels from naltrexone implants can block very large amounts of heroin: a report of two cases.
    Brewer C
    Addict Biol; 2002 Jul; 7(3):321-3. PubMed ID: 12126492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open-label trial of oral nalmefene therapy for the pruritus of cholestasis.
    Bergasa NV; Schmitt JM; Talbot TL; Alling DW; Swain MG; Turner ML; Jenkins JB; Jones EA
    Hepatology; 1998 Mar; 27(3):679-84. PubMed ID: 9500694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opiate-receptor antagonist nalmefene improves neurological recovery after traumatic spinal cord injury in rats through a central mechanism.
    Faden AI; Sacksen I; Noble LJ
    J Pharmacol Exp Ther; 1988 May; 245(2):742-8. PubMed ID: 3367315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human pharmacology and abuse potential of nalmefene.
    Fudala PJ; Heishman SJ; Henningfield JE; Johnson RE
    Clin Pharmacol Ther; 1991 Mar; 49(3):300-6. PubMed ID: 2007323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of a sensitive liquid chromatographic/tandem mass spectrometric method to pharmacokinetic study of nalmefene in humans.
    Li P; Chen X; Dai X; Wen A; Zhang Y; Zhong D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):479-84. PubMed ID: 17329173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer of naltrexone and its metabolite 6,beta-naltrexol into human milk.
    Chan CF; Page-Sharp M; Kristensen JH; O'Neil G; Ilett KF
    J Hum Lact; 2004 Aug; 20(3):322-6. PubMed ID: 15296587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
    Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute pulmonary edema in a young male after intravenous nalmefene.
    Henderson CA; Reynolds JE
    Anesth Analg; 1997 Jan; 84(1):218-9. PubMed ID: 8989029
    [No Abstract]   [Full Text] [Related]  

  • 20. Nalmefene for elective reversal of procedural sedation in children.
    Chumpa A; Kaplan RL; Burns MM; Shannon MW
    Am J Emerg Med; 2001 Nov; 19(7):545-8. PubMed ID: 11698998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.